Breaking News

Oncobiologics Opens Commercial Launch Manufacturing Facility

The new facility has already been deployed to manufacture a Humira biosimilar candidate in an upcoming Phase III trial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing monoclonal antibody (mAb) biosimilars, has completed the construction of its GMP commercial launch manufacturing facility at its headquarters in Cranbury, NJ. The Cranbury facility is designed to utilize multiple technologies that enable rapid deployment of flexible manufacturing at commercial scale. Through the use of the latest single-use technologies, the company says the facility footprint and associa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters